| pubmed-article:11351346 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0007138 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0600139 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C1522721 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C1882365 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C1706701 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:11351346 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
| pubmed-article:11351346 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11351346 | pubmed:dateCreated | 2001-5-14 | lld:pubmed |
| pubmed-article:11351346 | pubmed:abstractText | In vitro and experimental studies of mesenchymal-epithelial interaction for the prostatic stroma have demonstrated that the prostatic stroma is capable of inducing the nonprostatic epithelium to acquire many features of prostatic epithelium. We investigated whether this phenomenon could be observed in vivo in human prostatic stroma. MATERIALS AND METHODS Sixty transitional cell carcinoma (TCC) of the urinary bladder: (a) 20 with glandular lumen; (b) 20 without glandular lumen: (c) 10 mixed TCC-adenocarcinoma (ACA); and (d) 10 with synchronous or metachronous TCC of the prostate; and three primary TCC of the prostate were examined and submitted for immunostaining for prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA). | lld:pubmed |
| pubmed-article:11351346 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11351346 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11351346 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11351346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11351346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11351346 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11351346 | pubmed:month | May | lld:pubmed |
| pubmed-article:11351346 | pubmed:issn | 0270-4137 | lld:pubmed |
| pubmed-article:11351346 | pubmed:author | pubmed-author:FarmerJJ | lld:pubmed |
| pubmed-article:11351346 | pubmed:author | pubmed-author:YazdiH MHM | lld:pubmed |
| pubmed-article:11351346 | pubmed:author | pubmed-author:KivI III | lld:pubmed |
| pubmed-article:11351346 | pubmed:copyrightInfo | Copyright 2001 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:11351346 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11351346 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11351346 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:11351346 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11351346 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11351346 | pubmed:pagination | 172-82 | lld:pubmed |
| pubmed-article:11351346 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:meshHeading | pubmed-meshheading:11351346... | lld:pubmed |
| pubmed-article:11351346 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11351346 | pubmed:articleTitle | Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma. | lld:pubmed |
| pubmed-article:11351346 | pubmed:affiliation | Division of Anatomical Pathology, Department of Laboratory Medicine, The Ottawa Hospital Civic Campus, Ottawa, Ontario, Canada. ktmai@civich.ottawa.on.ca | lld:pubmed |
| pubmed-article:11351346 | pubmed:publicationType | Journal Article | lld:pubmed |
